PM
PneumoNIX Medical develops a device that utilizes real-time imaging and precise needle guidance to enhance the accuracy of soft-tissue cancer biopsies. This technology minimizes the risks of bleeding and infection, significantly improving patient safety during procedures.
Updated 4 months ago
Funding
$1M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- PneumoNIX Medical develops a device that utilizes real-time imaging and precise needle guidance to enhance the accuracy of soft-tissue cancer biopsies. This technology minimizes the risks of bleeding and infection, significantly improving patient safety during procedures.